BIOCRYST PHARMACEUTICALS's ticker is and the CUSIP is 09058V903. A total of 3 filers reported holding BIOCRYST PHARMACEUTICALS in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $1,140,000 | -55.7% | 2,584 | +50.1% | 0.04% | -54.3% |
| Q2 2015 | $2,571,000 | +170.1% | 1,722 | +63.4% | 0.09% | +135.0% |
| Q1 2015 | $952,000 | -20.5% | 1,054 | -33.1% | 0.04% | -47.4% |
| Q4 2013 | $1,198,000 | +168.6% | 1,576 | +157.1% | 0.08% | +162.1% |
| Q3 2013 | $446,000 | – | 613 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 2,584 | $1,140,000 | 0.04% |
| GROUP ONE TRADING, L.P. | 65,600 | $289,000 | 0.00% |
| SIMPLEX TRADING, LLC | 119 | $4,000 | 0.00% |